Allegion to Attend 2026 Wells Fargo Industrials & Materials Conference June 2, 2026 Allegion plc (NYSE: ALLE) President and CEO John H. Stone will discuss the company’s long-term strategy at the 2026 Wells Fargo Industrials & Materials Conference on Tuesday, June 9. The conference will be held at Loews Chicago Hotel. A live listen-only webcast will be accessible via Allegion’s investor website at investor.allegion.com or directly by clicking [...]
ThetaRay Gamifies Financial Defense at Money20/20 Europe with a Compliance Twist on “Where’s Waldo” June 2, 2026 With “Spot The Money Mule”, ThetaRay unites Agentic AI and public education to disrupt criminal recruitment; pushing for an ecosystem-wide stand against illicit finance.
Bidgely’s EmPOWER AI London Convenes Leaders to Map the Future of Electrification, Load Flexibility, Customer Experience and Energy Affordability May 28, 2026 New LCP Delta report anchors an interactive agenda, driving candid conversations with independent researchers and regional visionaries
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference May 27, 2026 Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55 p.m. ET. A live webcast can be accessed in the Investors section of the [...]
Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting May 26, 2026 — Company to Present 11 Posters Demonstrating Commitment to Advancing Innovative Research for People Living With Chronic Psychiatric and Neurological Disorders —
Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences May 21, 2026 – Real-World Evidence of Positive Impact of LYBALVI® (olanzapine and samidorphan) on Treatment Patterns and Rates of Relapse Among Patients with Schizophrenia or Bipolar I Disorder, Including Young Adults – – APA Plenary Presentation Highlights Recent Clinical Data, Including Results for Negative Symptoms and Outcomes From Four Years of Treatment, and Real-World Evidence From Use of LYBALVI (olanzapine and samidorphan) in Clinical Practice –
Xsolla and the Dubai Films and Games Commission Create a Strategic Partnership to Connect Dubai-Based Developers to Global Markets May 21, 2026 Multi-Year Agreement Creates Opportunities to Build All The Things for Video Games in Dubai and MENA
Xsolla Expands Nordic Presence With Industry Engagements Across Sweden, Including Official Sponsorship of Nordic Game 2026 May 20, 2026 Coordinated Activations Across Sweden Underscore Xsolla’s Continued Investment In The Nordic Games Ecosystem, Bringing Developers, Partners, And Creators Together
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June May 19, 2026 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, Fla. Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial Officer; and Phil Kowalczyk, Chief Strategy and Corporate Development Officer, will participate in a fireside chat on [...]
Money20/20 Europe Announces Powerhouse Speaker Lineup Featuring Leaders from Klarna, BBVA, ABN AMRO, Mastercard, eToro, and Revolut May 19, 2026 Leading voices in payments, banking, and fintech innovation to take the stage in Amsterdam